Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
Use this ORGO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ORGO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ORGO SEC filings page. Lician reads the product cache first so this HTML stays unique to Organogenesis Holdings Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ORGO income, balance, and cash tables.